Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RAD - Radiopharm Theranostics talks clinical development and Nasdaq listing

RAD - Radiopharm Theranostics talks clinical development and Nasdaq listing

Rite Aid Corporation

(NewsDirect)

Radiopharm Theranostics Ltd (ASX:RAD) CEO and managing directorRiccardo Canevari tells Proactive the company has begun the initiationprocess for entry into the Nasdaq stock exchange under the tickerRADX, gaining a second listing in the US capital market. RAD’srecently announced that it has received US FDA Investigational NewDrug Application (IND) approval for its ?V?6 Integrin (RAD301)technology. With this approval the company can start a Phase 1 imagingtrial in ambulatory patients with pancreatic cancer.

ContactDetails

Proactive Investors

JonathanJackson

+61 413 713 744

jonathan@proactiveinvestors.com

Copyright (c) 2023 TheNewswire - All rights reserved.

Stock Information
Company Name: Rite Aid Corporation
Stock Symbol: RAD
Market: NYSE
Website: riteaid.com
Menu
RAD RAD Quote RAD Short RAD News RAD Articles RAD Message Board
Get RAD Alerts

News, Short Squeeze, Breakout and More Instantly...